Senti Biosciences (SNTI) Stock Statistics & Valuation Metrics

Senti Biosciences has a market cap or net worth of $31.55M. The enterprise value is $64.77M.

Senti Biosciences has 26,290,838 shares outstanding. The number of shares has decreased by -2.65% in one year.

Senti Biosciences’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -68.24%.

The current PE Ratio of Senti Biosciences is ―. Senti Biosciences’s PEG ratio is 0.00677.

In the last 12 months, Senti Biosciences had revenue of 0.00 and earned -52.79M in profits. Earnings per share was -11.49.

In the last 12 months, operating cash flow was -50.07M and capital expenditures -207.00K, giving a free cash flow of -50.28M billion.

Senti Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Senti Biosciences upcoming earnings date is May 12, 2026, After Close (Confirmed).

Senti Biosciences as a current ratio of 4.49, with Debt / Equity ratio of 370.90%

In the past 12 months, Senti Biosciences has paid 0.00 in taxes.

Senti Biosciences EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.

Senti Biosciences has $12.24M in cash and marketable securities with $30.12M in debt, giving a net cash position of -$17.88M billion.

Gross margin is 24.80%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Senti Biosciences is $12.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy